-
New CFB inhibitors disclosed in Guangzhou Runer Ophthalmic Biotechnology patent
13 Jan 2026 20:59 GMT
Ocular
Guangzhou Runer Ophthalmic Biotechnology Co. Ltd. has divulged compounds acting as complement factor B (CFB) inhibitors reported to be useful for the treatment of age-related macular degeneration, diabetic retinopathy, uveitis, retinitis pigmentosa, …
-
Scienco Biotech patents milk testing method
13 Jan 2026 20:16 GMT
The Brazilian startup Scienco Biotech has developed and patented a technology capable of identifying milk that is free of a protein associated with poor digestion. It is a test performed immediately after milking the animal, similar to a pregnancy test. …
-
PRMT5 inhibitors disclosed in Shanghai Apeiron Biotechnology patent
25 Nov 2025 17:06 GMT
Cancer
Shanghai Apeiron Biotechnology Co. Ltd. has divulged protein arginine N-methyltransferase 5 (PRMT5) inhibitors reported to be useful for the treatment of brain metastatic cancer.
BioWorld Science Cancer Patents
-
The new treaty is a patent
15 Jan 2026 10:04 GMT
… vector of IP diffusion.
3) Biotech: patents are no longer just about …
-
Shanghai Apeiron Biotechnology patents new PRMT5 degradation inducers
06 Nov 2025 01:10 GMT
-
AI cracks the code for faster, better crops
15 Jan 2026 01:50 GMT
… controls the majority of core biotechnology patents," he added.
China…
-
Beijing Avistone Pharmaceuticals Biotechnology patents new HER2 inhibitors
10 Oct 2025 18:39 GMT
Cancer
Beijing Avistone Pharmaceuticals Biotechnology Co. Ltd. has disclosed spiro/bridged ring compounds acting as HER2 (erbB2) (exon 20 insertion [Ex20Ins] [Ala775_Gly776insTyrValMetAla mutant]) inhibitors reported to be useful for the treatment of …
-
GLP-1R agonists disclosed in Shanghai Yidi Biotechnology patent
15 Sep 2025 22:44 GMT
-
New indazoles disclosed in Nova Biotechnology patent
02 Sep 2025 15:17 GMT
-
Shenzhen Zhongge Biotechnology patents new PARP-7 inhibitors
30 May 2025 23:02 GMT
Cancer
Shenzhen Zhongge Biotechnology Co. Ltd. has disclosed protein mono-ADP-ribosyltransferase TIPARP (PARP-7; ARTD14) inhibitors reported to be useful for the treatment of inflammatory disorders, immunological disorders, viral infections and cancer.
…